Dear Colleague:
In the last year, I have had the good fortune to visit with Song Ruilin several times during my travels to China. Professor Song is the Executive Director-General of the China Pharmaceutical Association's Research Center for Medicinal Policy and Chairman of the Chinese Journal of New Drugs. He is among the most influential figures in China healthcare reform and pharmaceutical policy. He rarely speaks publicly and seldom visits the U.S.
Top China Health Reform Insider To Speak At PharmAsia Summit In San Francisco
Song Ruilin has agreed to give a keynote talk at the PharmAsia Summit (Oct. 26-28, San Francisco, Calif.) about China healthcare reform and its impact on the pharmaceutical and medical device industries. To find out more: Click Here.
This is a remarkable opportunity to hear the viewpoints of a key insider on China health policy. If you have questions about how China health reform will impact your business - and it will - this is a must-attend event for you and your team.
I can ensure you that Professor Song's perspectives will provide you with actionable intelligence about China healthcare reform, so you can take advantage of China's booming market and avoid being left behind.
With the Chinese government launching wide-ranging health reforms this year, with a goal of extending medical insurance to all Chinese citizens, these reforms will have a profound impact on the biopharma and medical device industries.
If you have questions about the following issues, you must attend the PharmAsia Summit (Oct. 26-28, San Francisco, Calif.) and hear from Song Ruilin:
- How will China's new essential medicine list impact my commercial opportunities in China?
- Will China's healthcare reforms ensure premium prices for innovative therapies?
- Which drugs and medical devices will benefit most from China's reforms?
- How will changes to hospital reimbursement practices impact drug utilization?
- In what manner will China regulate biosimilars?
- And much more
Professor Song Ruilin is one of many experts from China and India who will be speaking at the PharmAsia Summit (Oct. 26-28, San Francisco, Calif.). To view the full conference agenda and register online, please click here.
Sincerely,
Joshua L. Berlin
Executive Editor & Senior Publications Manager, Elsevier Business Intelligence
P.S. This is the only conference in the U.S. where you will hear directly from Song Ruilin and other key insiders from China and India. Check out our PharmAsia Summit DealMakers Value Package for an unbeatable discount on the PharmAsia Summit.
